- Previous Close
5.95 - Open
6.00 - Bid 5.30 x --
- Ask 5.90 x --
- Day's Range
5.20 - 6.00 - 52 Week Range
3.40 - 8.95 - Volume
5,571,480 - Avg. Volume
4,352,423 - Market Cap (intraday)
60.06M - Beta (5Y Monthly) 1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.02 - Earnings Date Mar 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.40
Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It makes minority investments in portfolio companies. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. The firm prefers to invest from its balance sheet capital. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.
www.agronomics.imRecent News: ANIC.L
View MorePerformance Overview: ANIC.L
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANIC.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANIC.L
View MoreValuation Measures
Market Cap
52.69M
Enterprise Value
42.50M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.35
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-6.35%
Return on Equity (ttm)
-10.74%
Revenue (ttm)
-14.68M
Net Income Avi to Common (ttm)
-17.11M
Diluted EPS (ttm)
-0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
150.78M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-10.13M